Evolution of Herpes Zoster Vaccines and Their Economic Value
- PMID: 29297047
- DOI: 10.1001/jamainternmed.2017.7442
Evolution of Herpes Zoster Vaccines and Their Economic Value
Comment on
-
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.JAMA Intern Med. 2018 Feb 1;178(2):248-258. doi: 10.1001/jamainternmed.2017.7431. JAMA Intern Med. 2018. PMID: 29297049 Free PMC article.
Similar articles
-
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine.JAMA Intern Med. 2018 Jun 1;178(6):873. doi: 10.1001/jamainternmed.2018.2029. JAMA Intern Med. 2018. PMID: 29868745 No abstract available.
-
Limited Focus in Evaluation of Vaccine Cost-effectiveness.JAMA Intern Med. 2018 Nov 1;178(11):1563-1564. doi: 10.1001/jamainternmed.2018.5801. JAMA Intern Med. 2018. PMID: 30398554 No abstract available.
-
Limited Focus in Evaluation of Vaccine Cost-effectiveness-Reply.JAMA Intern Med. 2018 Nov 1;178(11):1564. doi: 10.1001/jamainternmed.2018.5804. JAMA Intern Med. 2018. PMID: 30398559 No abstract available.
-
[Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio].Presse Med. 2016 Feb;45(2):162-76. doi: 10.1016/j.lpm.2015.10.015. Epub 2015 Dec 24. Presse Med. 2016. PMID: 26724874 Review. French.
-
Herpes zoster and vaccination: a clinical review.Am J Health Syst Pharm. 2010 May 1;67(9):724-7. doi: 10.2146/ajhp090118. Am J Health Syst Pharm. 2010. PMID: 20410546 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
